Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Clinical trial NCT02250105 · COMPLETED
Trial details
- NCT number
- NCT02250105
- Sponsor
- Arisaph Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.